Asian Currencies Weaken as Dollar, Oil Prices Rise 
UK Housebuilder Stocks Surge on New First-Time Buyer Loan Scheme 
US Stocks Slip as Treasury Yields Ease, AI Trade Rebounds 
RBA Hikes Interest Rate to 4.60% as Inflation Risks Rise 
Asian Currencies Mixed as Yen Weakens, RBA Hike Looms 
BlackRock’s Rick Rieder Favors Bonds Over Stocks as Treasury Yields Surge 
U.S. Stock Futures Steady as AI, Rate Concerns Weigh 
Trump Eyes $54 Billion South Korean Investment in Alaska LNG 
U.S. Stock Futures Fall as Iran, Oil and AI Risks Rattle Markets 
Australia Budget Deficit Narrows to A$22.3 Billion on Stronger Tax Revenue 
Gold Holds Near Seven-Week Low as Fed Rate Hike Bets Rise 
Japan Warns Markets Over Yen Weakness 
South Korea Exports Set for 16th Monthly Gain on AI Chip Demand 
Asian Chip Stocks Tumble as OpenAI Safety Pause Sparks AI Growth Concerns 
XRP Price Targets $1.70 as Bullish Momentum Builds 
US Dollar Hits Two-Month High as Aussie, Pound Slide 
Asian Stocks Fall as Oil Surge, Bond Yields and AI Concerns Hit Markets 
Add as a preferred source on Google
Eli Lilly to Introduce Mounjaro Weight-Loss Drug in Hong Kong by Year-End
Global pharmaceutical giant Eli Lilly is gearing up to launch its weight-loss drug, Mounjaro, in Hong Kong by the end of this year. According to a report from Bloomberg News, the company has received approval from Hong Kong's government to sell its tirzepatide injections under the Mounjaro brand.
Mounjaro for Weight Management and Diabetes
Eli Lilly's Mounjaro is designed for both long-term weight management and the treatment of type 2 diabetes. It will be available on the Kwikpen device, which allows for easy self-administration. The company aims to address the growing demand for effective weight-loss treatments while continuing to provide solutions for diabetes management.
Hong Kong Market Entry
Hong Kong marks a strategic entry point for Eli Lilly as it expands its global presence. With the approval of Mounjaro, the company is poised to offer a highly anticipated solution for individuals struggling with obesity and related health issues. The weight-loss sector has seen significant growth in recent years, and Mounjaro is expected to make a notable impact.
